Sotera Health (NASDAQ:SHC) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Sotera Health (NASDAQ:SHC) have received an average recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $16.50.

A number of analysts have recently issued reports on SHC shares. Royal Bank of Canada reiterated an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a research note on Tuesday, August 6th. Barclays lifted their price target on shares of Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 6th. Finally, Citigroup upped their price objective on shares of Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th.

Sotera Health Stock Down 2.9 %

Shares of Sotera Health stock opened at $13.21 on Thursday. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44. The stock has a market cap of $3.74 billion, a price-to-earnings ratio of 52.84 and a beta of 2.08. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The company has a fifty day moving average price of $15.77 and a 200 day moving average price of $13.94.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). The company had revenue of $285.47 million during the quarter, compared to analysts’ expectations of $278.64 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. Sotera Health’s quarterly revenue was up 8.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.18 EPS. Equities research analysts forecast that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $15.03, for a total value of $150,300,000.00. Following the completion of the transaction, the director now directly owns 49,215,301 shares of the company’s stock, valued at approximately $739,705,974.03. The trade was a 16.89 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 55.12% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Sotera Health

Several institutional investors have recently modified their holdings of SHC. Wedmont Private Capital increased its position in Sotera Health by 6.5% in the 3rd quarter. Wedmont Private Capital now owns 10,915 shares of the company’s stock valued at $169,000 after acquiring an additional 664 shares during the period. First Citizens Bank & Trust Co. increased its holdings in shares of Sotera Health by 5.0% during the third quarter. First Citizens Bank & Trust Co. now owns 14,287 shares of the company’s stock valued at $239,000 after purchasing an additional 677 shares during the period. CWM LLC increased its holdings in shares of Sotera Health by 86.1% during the second quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after purchasing an additional 993 shares during the period. Swiss National Bank raised its stake in shares of Sotera Health by 0.5% during the first quarter. Swiss National Bank now owns 195,900 shares of the company’s stock valued at $2,353,000 after purchasing an additional 1,000 shares in the last quarter. Finally, GAMMA Investing LLC lifted its holdings in Sotera Health by 125.0% in the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock worth $50,000 after purchasing an additional 1,660 shares during the period. Institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.